Literature DB >> 10826263

Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide.

D F Heinemann1.   

Abstract

During the past decade, numerous organizations and associations have published recommendations for the prevention and treatment of osteoporosis. For the primary care physician, the most applicable of these--due to its reliance on clinical trial data and its scope--is the clinical guide published by the National Osteoporosis Foundation. The guide addresses risk assessment, bone mineral density testing, diagnosis, nutritional supplementation, and pharmacologic therapy, including consideration of the newer agents used to slow or manage osteoporosis progression. Reflecting one of the key deficiencies in the clinical trial data, the guide applies predominantly to a patient population of postmenopausal white females. The refined design of new osteoporosis studies will in time allow for recommendations that apply to a more diverse patient population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826263

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  14 in total

1.  Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data.

Authors:  Joanne LaFleur; Carrie McAdam-Marx; Stephen S Alder; Xiaoming Sheng; Carl V Asche; Jonathan Nebeker; Diana I Brixner; Stuart L Silverman
Journal:  J Bone Miner Metab       Date:  2010-08-06       Impact factor: 2.626

2.  Diabetic serum from older women increases adipogenic differentiation in mesenchymal stem cells.

Authors:  Kendall F Moseley; Máire E Doyle; Suzanne M Jan De Beur
Journal:  Endocr Res       Date:  2018-03-09       Impact factor: 1.720

Review 3.  [Degeneration and osteoporosis of the spine. Is there a modified procedure?].

Authors:  K-S Delank; M Röllinghoff; K Eysel-Gosepath; R Sobottke; P Eysel
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

Review 4.  Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate.

Authors:  Charles H Chesnut
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  A randomized, controlled trial of disability prevention in frail older patients screened in primary care: the FRASI study. Design and baseline evaluation.

Authors:  Stefania Bandinelli; Fulvio Lauretani; Vittorio Boscherini; Francesca Gandi; Martina Pozzi; Anna Maria Corsi; Benedetta Bartali; Raffaello Molino Lova; Jack M Guralnik; Luigi Ferrucci
Journal:  Aging Clin Exp Res       Date:  2006-10       Impact factor: 3.636

6.  Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration.

Authors:  Jin Hee Kwak; Yulong Zhang; Juyoung Park; Eric Chen; Jia Shen; Chirag Chawan; Justine Tanjaya; Soonchul Lee; Xinli Zhang; Benjamin M Wu; Kang Ting; Chia Soo
Journal:  Biomaterials       Date:  2015-04-24       Impact factor: 12.479

7.  Clinical utility of laboratory testing in women with osteoporosis.

Authors:  Sophie A Jamal; Richard E Leiter; Ahmed M Bayoumi; Douglas C Bauer; Steven R Cummings
Journal:  Osteoporos Int       Date:  2004-08-31       Impact factor: 4.507

8.  Bone mineral density and diet of teachers of College of Home Economics at Lahore.

Authors:  Zahra Javed; Sardar Fakhar Imam; Neelam Imam; Kanwal Saba; Mulazim Hussain Bukhari
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

9.  Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes.

Authors:  Hai-Ling Chen; Li-Li Deng; Ju-Fen Li
Journal:  Int J Endocrinol       Date:  2013-01-17       Impact factor: 3.257

10.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.